Investor Relations

Camilla Myhre Sandberg, CEO

Camilla has 25 years’ experience in Life Science and has a Cand. Scient degree in toxicology from the University of Oslo. She has extensive experience in business development, contractual negotiations, mergers & acquisition, and all elements of strategic and tactical marketing, including market research and analysis, brand creation, and market communication. 

Camilla has held positions at Dynal Biotech, GE Healthcare and BioLamina AB before joining Miris in 2016. Through her work she has developed expertise in development and establishment of new clinical markets for medical devices and consumable products, and in Cell Therapy & Regenrative Medicine.

Shares in Miris Holding AB: 10 140 660 shares, 3 618 315 options 

Pernilla Nordahl, Finance Director

Pernilla has 17 years of experience in economics and has a Bachelor degree in Business Administration. She has worked as accounting consultant since 2007 and comes from a position as Office Area Leader at Aspia, Västerås before joining Miris on consultancy basis 2021.    

Shares in Miris Holding AB: 0 shares

Marie Ekholm, Sales Director

Marie has a background in Life Science with a PhD from the medical faculty at Uppsala University and joined Miris as an Account Manager in 2016 and was promoted to Sales Director in 2018. As Sales Director she not only manages the sales at Miris but also take part in the spreading of Miris mission, to increase awareness, support researchers and enable doctors to individualise human milk fortification, by giving lectures on the concept of target fortification and Human Milk Analysis at Hospitals around the world.

Shares in Miris Holding AB: 2 067 498 shares, 736 785 options

Elin Hallén, Director Regulatory Affairs

Elin has a background in Food Science, with a PhD from the Swedish University of Agricultural Sciences (SLU) where she also worked as a researcher before joining Miris in 2010. This meant switching from a research focus on bovine milk, to working with human milk and preterm nutrition.  At Miris Elin has worked in various positions, from production and technical support to quality control and regulatory affairs. Since 2014 Elin’s main commitment has been within regulatory affairs, with the specific aim to bring Miris to the US market. She was appointed Director of Regulatory Affairs 2021.

Shares in Miris Holding AB: 0 shares

Anna Pallas, QA Director

Anna has a background in Life Science with a PhD from the Department of Chemistry at Uppsala University. She has a long experience in quality assurance and has been working in various medical device companies, mostly as QA Manager, but also as a QA consultant. In the role as QA consultant Anna participated during the implementation of Miris new quality management system. She joined Miris as QA Director 2023.

Shares in Miris Holding AB: 99 988 shares, 35 710 options